Hepatitis

Efforts to eliminate new hepatitis C cases by 2030, a goal set by the World Health Organization (WHO), are falling short in high-risk groups,…

A new test that uses a tiny drop of blood collected from a finger prick and returns results in about an hour can detect…

Dosing has begun in a Phase 1/2 clinical trial testing CRMA-1001, Nchroma Bio’s experimental epigenetic therapy being studied as a potential functional cure for…

Huahui Health‘s Libevitug has become the first approved treatment for chronic hepatitis D virus (HDV) infection in China. The country’s National Medical Products Administration…

After about two years of treatment with the experimental therapies tobevibart and elebsiran, nearly nine out of 10 evaluable…

Bepirovirsen added to standard-of-care medications led to higher functional cure rates for people with chronic hepatitis B than standard treatments alone, according to top-line…

Health Canada has expanded its approval of Abbvie’s oral therapy Maviret (glecaprevir/pibrentasvir), making it the first eight-week, pan-genotypic treatment available for both acute and…

Throughout 2025, the team at Liver Disease News has reported on the latest research and advances in care related to various rare and non-rare liver…

Researchers in the U.S. have developed a rapid point-of-care test that detects active hepatitis C infection by identifying HCV RNA, with results available in…

Major medical associations and state health departments are moving to maintain the standard of universal hepatitis B vaccination at birth, diverging from a recent…